Latest Content
Senior Insights Executive with proven consumer and shopper analytic acumen. Respected and sought out for ability to develop a comprehensive view of marketplace dynamics - uncovering unique perspectives and growth opportunities for Fortune 500 organizations. Welcomes and approaches challenges with intellectual curiosity and leadership.
Notable contributions include:
• Leveraged Emerging Trends To Uncover Unique Growth Opportunities: Spearheaded IRI’s study on Self-Care. Presented and provided strategic consulting to senior manufacturer and retailer executives on ways to leverage this forward looking, disruptive macro trend to maximize share within the $400 billion Self-Care market.
• Realized Incremental Growth Opportunities By Improving Success Of New Product Launches: Supported highly successful Rx-to-OTC switches (example Nexium® 24HR) from pre-launch to post by developing comprehensive consumer and shopper landscape analyses, simulating sales forecasts and war-gaming, recommending tactics to optimize marketing spend, and constructing post-launch tracking to improve the odds of success.
• Optimized Acquisition Value: IRI lead in due diligence phase for the acquisition of Pfizer Consumer Healthcare by Johnson & Johnson. Provided match with McNeil Consumer Healthcare portfolio fit and revenue potential from Zyrtec® Rx to over-the-counter switch.
• Harnessed Disparate Data Sources To Inform Strategy: Handpicked by divisional president to head IRI’s contributions to the General Merchandise Distributors Council (GMDC) Educational Foundation study “Leveraging the Connection of Pharmacy and Whole Store”. Tied together multiple unstructured data sources (IRI, WSL Strategic Research and public) to inform total store growth strategy.
• Deep CPG expertise with focus on Consumer Healthcare, Nutritionals, Beauty, Personal Care and Baby.